Documentation
Quantitative reverse transcription polymerase chain reaction results as a non-biased powerful epidemiological indicator
Last updated: 2023-02-03 03:36
Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria
Last updated: 2023-02-03 03:36